MedTrace Logo

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

NCT04456140 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2023-07-24

No results posted yet for this study

Summary

This phase I trial collects blood samples to investigate the prevalence of changes in genes (genetic mutations) in solid tumor patient populations seeking care at Mayo Clinic Embedded Cancer Center at St. Vincent's Riverside. This may help doctors better understand and/or treat others who have genetic mutations.

Conditions

  • Breast Carcinoma
  • Digestive System Neoplasm
  • Malignant Brain Neoplasm
  • Malignant Central Nervous System Neoplasm
  • Malignant Female Reproductive System Neoplasm
  • Malignant Genitourinary System Neoplasm
  • Malignant Head and Neck Neoplasm
  • Malignant Musculoskeletal Neoplasm
  • Malignant Solid Neoplasm
  • Metastatic Malignant Neoplasm of Unknown Primary
  • Skin Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Genetic Counseling

Watch pre-test genetic counseling video

OTHER

Genetic Testing

Undergo genetic testing

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

Principal Investigators

  • Niloy J Samadder · Mayo Clinic

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-29
Primary Completion
2021-09-21
Completion
2021-09-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456140 on ClinicalTrials.gov